Ani Pharmaceuticals (ANIP) Revenue (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Revenue of $237.5 million for Q1 2026, down 3.88% sequentially from $247.1 million in Q4 2025, and up 20.46% YoY from $197.1 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Revenue (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Revenue for 17 years, with the latest figure at $237.5 million in Q1 2026.
- Quarterly Revenue rose 20.46% year-over-year to $237.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $923.7 million (up 37.03% YoY) and the FY2025 annual result came in at $883.4 million, up 43.78% from the prior year.
- Revenue eased to $237.5 million in Q1 2026 per ANIP's latest filing, from $247.1 million in the prior quarter.
- Over five years, Revenue peaked at $247.1 million in Q4 2025 and troughed at $64.5 million in Q1 2022.
- A 5-year average of $149.3 million and a median of $137.4 million in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2024: Revenue surged 475.69% in 2022, then climbed 12.52% in 2024.
- Over 5 years, Revenue stood at $94.2 million in 2022, then jumped by 39.71% to $131.7 million in 2023, then surged by 44.75% to $190.6 million in 2024, then advanced by 29.64% to $247.1 million in 2025, then slipped by 3.88% to $237.5 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $237.5 million, $247.1 million, and $227.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 266.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 266.04 Mn |
| Mar 31, 2026 | 237.46 Mn |
| Dec 31, 2025 | 247.06 Mn |
| Sep 30, 2025 | 227.81 Mn |
| Jun 30, 2025 | 211.37 Mn |
| Mar 31, 2025 | 197.12 Mn |
| Dec 31, 2024 | 190.57 Mn |
| Sep 30, 2024 | 148.33 Mn |
| Jun 30, 2024 | 138.04 Mn |
| Mar 31, 2024 | 137.43 Mn |
| Dec 31, 2023 | 131.65 Mn |
| Sep 30, 2023 | 131.83 Mn |
| Jun 30, 2023 | 116.55 Mn |
| Mar 31, 2023 | 106.79 Mn |
| Dec 31, 2022 | 94.23 Mn |
| Sep 30, 2022 | 83.82 Mn |
| Jun 30, 2022 | 73.86 Mn |
| Mar 31, 2022 | 64.48 Mn |
| Dec 31, 2021 | 60.93 Mn |
| Sep 30, 2021 | 52.06 Mn |